Direkt zu den Inhalten springen

Covid-19 News

Considering the current legal situation and our hygiene and safety precautions, clinical studies can only be carried out to a limited extent. In this respect, in a first phase after the outbreak of the pandemic and the associated impact on our service as a research institute, we were focused on finalizing projects that had already started. We have largely succeeded in doing this. Projects that were planned but had not started at the time of the outbreak were postponed – in close consultation with our customers – until a later date.

A second phase is currently starting for us: While maintaining the strictest safety precautions, we are ready to conduct new projects and corresponding studies clinically. Among others, the following protective measures are to be considered:

  • A safety distance of at least 2 meters and / or the use of physical protection such as B. plexiglass
  • Obligatory wearing of respiratory masks for proderm employees and study subjects
  • Disinfection of the hands of proderm employees and study subjects is mandatory; at the same time we regularly carry out surface disinfection e.g. on door handles

The studies that can be carried out under these conditions are characterized by a small number of subjects and a limited number of examinations. In addition, we are currently working on remote trials. These could take into account surveys, self-assessments by the subjects, application controls and dermatological assessments.

Our business development team is happy to provide you with more detailed information on the study types. Please contact the email request(at)proderm.de.

proderm is now part of SGS proderm is now part of SGS